Nutraceuticals show promising results for hair growth in women

Video

We sat down with Glynis Ablon, MD, FAAD to learn about her research on nutraceuticals for hair growth in midlife.

Roughly 40% of women over 60 will experience female pattern hair loss, or androgenetic alopecia. However, new research from the University of California, Los Angeles, suggests nutraceuticals may be the key to hair growth in menopausal women.

Although there are several Food and Drug Administration (FDA)-approved drugs for male and female pattern hair loss, many women prefer more natural medications. The new study suggests that a nutraceutical supplement with nutrient-derived bioactive compounds may promote hair growth in perimenopausal, menopausal, and postmenopausal women.

Hear the perspective of lead author Glynis Ablon of the Ablon Skin Institute and Research Center in California, in the video above.

References

  1. Ablon G. Nutraceuticals. Dermatologic Clinics. 2021;39(3):417-427. doi:10.1016/j.det.2021.03.006
  2. Nutraceuticals May Be the Secret to a Full Head of Hair for Women at Midlife. Accessed September 24, 2021. https://www.menopause.org/docs/default-source/press-release/nutraceutical-supplement-for-promoting-hair-growth.pdf
Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
Hot flashes poorly impact sleep quality | Image Credit: intimmedicine.com
What's new in endometrium care? | Image Credit: nyulangone.org
How to manage bone health in midlife women | Image Credit: - endocrine.org
Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting | Image Credit: Yale School of Medicine
Highlights from The Menopause Society 2023 Annual Meeting  | Image Credit: nursebarb.com
How fezolinetant changes management of hot flashes | Image Credit: medschool.cuanschutz.edu.
Fezolinetant effective against vasomotor symptoms | Image Credit: med.unc.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.